Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antiviral strategies targeting host factors and mechanisms obliging +ssRNA viral pathogens
Supreeti Mahajan, Shweta Choudhary, Pravindra Kumar, et al.
Bioorganic & Medicinal Chemistry (2021) Vol. 46, pp. 116356-116356
Open Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

Molecular Mechanisms of Antiviral Agents against Dengue Virus
Michelle Felicia Lee, Yuan Seng Wu, Chit Laa Poh
Viruses (2023) Vol. 15, Iss. 3, pp. 705-705
Open Access | Times Cited: 50
Aryl hydrocarbon receptor is a proviral host factor and a candidate pan-SARS-CoV-2 therapeutic target
Jiandong Shi, Tingfu Du, Junbin Wang, et al.
Science Advances (2023) Vol. 9, Iss. 22
Open Access | Times Cited: 27
Navigating the Complex Landscape of Ebola Infection Treatment: A Review of Emerging Pharmacological Approaches
Francisca Almeida-Pinto, Rui Pinto, João Rocha
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 1, pp. 21-55
Open Access | Times Cited: 7
Applying genetic technologies to combat infectious diseases in aquaculture
Nicholas A. Robinson, Diego Robledo, Lene Sveen, et al.
Reviews in Aquaculture (2022) Vol. 15, Iss. 2, pp. 491-535
Open Access | Times Cited: 32
Recent Updates on Multifunctional Nanomaterials as Antipathogens in Humans and Livestock: Classification, Application, Mode of Action, and Challenges
Samreen Sadiq, Iltaf Khan, Zhenyu Shen, et al.
Molecules (2023) Vol. 28, Iss. 22, pp. 7674-7674
Open Access | Times Cited: 19
PROTACs in the Management of Prostate Cancer
Yedla Poornachandra, Ahmad O. Babalghith, Vindhya Vasini Andra, et al.
Molecules (2023) Vol. 28, Iss. 9, pp. 3698-3698
Open Access | Times Cited: 17
Structural and Functional RNA Motifs of SARS-CoV-2 and Influenza A Virus as a Target of Viral Inhibitors
Izabela Szczesniak, Agnieszka Baliga-Gil, Aleksandra Jarmolowicz, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1232-1232
Open Access | Times Cited: 16
Transformative Approaches in SARS-CoV-2 Management: Vaccines, Therapeutics and Future Direction
Ankita Saha, Shweta Choudhary, Priyanshu Walia, et al.
Virology (2025) Vol. 604, pp. 110394-110394
Closed Access
Suppression of Adipokinetic hormones enhances Ascovirus HvAV-3 h killing speed in Helicoverpa armigera
Zhengkun Xiao, Jiajun Gao, Jun Tang, et al.
Pesticide Biochemistry and Physiology (2025) Vol. 208, pp. 106303-106303
Closed Access
Host-targeted antivirals against SARS-CoV-2 in clinical development - prospect or disappointment?
André Schreiber, Stephan Ludwig
Antiviral Research (2025) Vol. 235, pp. 106101-106101
Open Access
Recent Advances in Antiviral Drug Delivery Strategies
Dhwani Rana, Arvee Prajapati, Bharathi Karunakaran, et al.
AAPS PharmSciTech (2025) Vol. 26, Iss. 3
Closed Access
Deciphering Host–Virus Interactions and Advancing Therapeutics for Chronic Viral Infection
Majid Eslami, Neda Arjmand, Fatemeh Mahmoudian, et al.
Viruses (2025) Vol. 17, Iss. 3, pp. 390-390
Open Access
Metabolomics of infectious diseases in the era of personalized medicine
Mahbuba Rahman, Herb E. Schellhorn
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 14
Quinones as Promising Compounds against Respiratory Viruses: A Review
Iván Chan‐Zapata, Rocı́o Borges-Argáez, Guadalupe Ayora‐Talavera
Molecules (2023) Vol. 28, Iss. 4, pp. 1981-1981
Open Access | Times Cited: 13
Emerging roles of the Protein Phosphatase 1 (PP1) in the context of viral infections
Pedro O. Corda, Mathieu Bollen, Daniela Ribeiro, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Association between Direct-Acting Agents Adherence and Health-Related Quality of Life of Patients with Hepatitis C.
Irina Paula Doica, Adina Turcu-Ştiolică, Bogdan Silviu Ungureanu, et al.
PubMed (2024) Vol. 49, Iss. 3, pp. 312-318
Closed Access | Times Cited: 4
Recent advances of engineered oncolytic viruses-based combination therapy for liver cancer
Junhe Zhang, Yunxi Xiao, Jie Zhang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Repurposing of SARS-CoV-2 compounds against Marburg Virus using MD simulation, mm/GBSA, PCA analysis, and free energy landscape
Sanjay Kumar, Rajni Dubey, Richa Mishra, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-20
Closed Access | Times Cited: 3
Biomolecular Condensates as Novel Antiviral Targets
Erik W. Martin, Christiane Iserman, Balaji Olety, et al.
Journal of Molecular Biology (2023) Vol. 436, Iss. 4, pp. 168380-168380
Open Access | Times Cited: 8
Inhibition of Pim kinases triggers a broad antiviral activity by affecting innate immunity and via the PI3K-Akt-mTOR axis the endolysosomal system
Mirco Glitscher, Nuka Ivalu Benz, Catarina Sabino, et al.
Antiviral Research (2024) Vol. 226, pp. 105891-105891
Open Access | Times Cited: 2
SRX3177, a CDK4/6-PI3K-BET inhibitor, in combination with an RdRp inhibitor, Molnupiravir, or an entry inhibitor MU-UNMC-2, has potent antiviral activity against the Omicron variant of SARS-CoV-2
Kabita Pandey, Arpan Acharya, Dhananjaya Pal, et al.
Antiviral Research (2024) Vol. 227, pp. 105904-105904
Closed Access | Times Cited: 2
Viral Hijacking of Host RNA-binding Proteins: Implications for Viral Replication and Pathogenesis
Angyiba Serge Andigema
Journal of Clinical and Laboratory Research (2024) Vol. 7, Iss. 5, pp. 01-06
Open Access | Times Cited: 2
Amidino-Rocaglates (ADRs), a class of synthetic rocaglates, are potent inhibitors of SARS-CoV-2 replication through inhibition of viral protein synthesis
Patrick T. Keiser, Wenhan Zhang, Michael Ricca, et al.
Antiviral Research (2024) Vol. 230, pp. 105976-105976
Closed Access | Times Cited: 2
Achieving Optimal Health With Host‐Directed Therapies (HDTs) in Infectious Diseases—A New Horizon
Amol D. Gholap, Pankaj R. Khuspe, Sagar R. Pardeshi, et al.
Advanced Therapeutics (2024)
Open Access | Times Cited: 2
Virus-host protein-protein interactions as molecular drug targets for arboviral infections
Mandar Bhutkar, Vishakha Singh, Preeti Dhaka, et al.
Frontiers in Virology (2022) Vol. 2
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top